Načítá se...

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis

David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dowdy, David W., Cattamanchi, Adithya, Steingart, Karen R., Pai, Madhukar
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2011
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3144197/
https://ncbi.nlm.nih.gov/pubmed/21814496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1001063
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!